- Home
- CSTL vs OLP Comparison
CSTL vs OLP Comparison
Compare CSTL & OLP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTL
- OLP
- Stock Information
- Founded
- CSTL 2007
- OLP 1982
- Country
- CSTL United States
- OLP United States
- Employees
- CSTL 784
- OLP N/A
- Industry
- CSTL Medical Specialities
- OLP Real Estate Investment Trusts
- Sector
- CSTL Health Care
- OLP Real Estate
- Exchange
- CSTL Nasdaq
- OLP Nasdaq
- Market Cap
- CSTL 456.2M
- OLP 569.9M
- IPO Year
- CSTL 2019
- OLP N/A
- Fundamental
- Price
- CSTL $15.95
- OLP $24.46
- Analyst Decision
- CSTL Strong Buy
- OLP Strong Buy
- Analyst Count
- CSTL 6
- OLP 1
- Target Price
- CSTL $37.67
- OLP $28.00
- AVG Volume (30 Days)
- CSTL 527.3K
- OLP 43.2K
- Earning Date
- CSTL 05-05-2025
- OLP 05-06-2025
- Dividend Yield
- CSTL N/A
- OLP 7.35%
- EPS Growth
- CSTL N/A
- OLP N/A
- EPS
- CSTL N/A
- OLP 1.35
- Revenue
- CSTL $347,083,000.00
- OLP $92,152,000.00
- Revenue This Year
- CSTL N/A
- OLP $11.87
- Revenue Next Year
- CSTL $1.80
- OLP $4.72
- P/E Ratio
- CSTL N/A
- OLP $18.17
- Revenue Growth
- CSTL 38.43
- OLP 3.31
- 52 Week Low
- CSTL $15.45
- OLP $22.32
- 52 Week High
- CSTL $35.84
- OLP $30.45
- Technical
- Relative Strength Index (RSI)
- CSTL 33.63
- OLP 53.35
- Support Level
- CSTL $15.45
- OLP $23.89
- Resistance Level
- CSTL $16.43
- OLP $24.72
- Average True Range (ATR)
- CSTL 0.59
- OLP 0.46
- MACD
- CSTL 0.04
- OLP 0.09
- Stochastic Oscillator
- CSTL 15.93
- OLP 81.82
About CSTL Castle Biosciences Inc.
Castle Biosciences Inc is a molecular diagnostics company. The group provides test solutions for the diagnosis and treatment of dermatologic cancers, Barrett's esophagus (BE), and uveal melanoma. The product portfolio of the company includes DecisionDx-Melanoma, a risk stratification gene expression profile (GEP) test; DecisionDx-SCC, a risk stratification test for cutaneous squamous cell carcinoma; MyPath Melanoma, a diagnostic GEP test for use in patients with difficult-to-diagnose melanocytic lesions; and TissueCypher, a test to predict future development of progression of high-grade dysplasia and/or esophageal cancer. It also provides DecisionDx-UM, a risk stratification GEP test. The company also offers its products to the skin cancer and gastroenterology markets.
About OLP One Liberty Properties Inc.
One Liberty Properties Inc is a self-administered and self-managed real estate investment trust. It acquires, owns, and manages a geographically diversified portfolio consisting mainly of industrial and, to a lesser extent, retail properties, many of which are subject to long-term net leases. The trust has approximately one hundred two properties located across several states in the United States of America. A majority of its revenue is generated in the form of rental income.